Lee Biosolutions Inc, a leading biotech company in the healthcare field serving the Global diagnostic industry announced that it will expand into a new 40,786 Sq.ft facility in the City of Maryland Heights end of 4th quarter 2014 . The need for a new space is in response to the companies rising growth into new markets and increased demand for its products.
The building was previously home to one of the KV Pharmaceuticals cutting edge facilities that dotted the surrounding business landscape in St. Louis County. The Increased analytical lab space is needed for Lee Bio’s increased growth for bioanalytical research and development projects and its ever expanding bulk manufacturing requirements. The added capacity and resources will help the company achieve its projected growth through 2017.
Burton Lee, President and CEO says ,”With the rapid growth we have seen over the last few years, our current facility was not able to keep up with demand. The new building supports our strategic objective to further expand our product lines, increase our capacity on key contract manufacturing products requiring larger cGMP processing clean rooms and to create operational efficiencies to meet our clients requirements.”
The company plans on doubling its payroll by 2016 and is currently seeking qualified candidates to fill several positions by first quarter next year. The company has set up a career page to easily fill out and send in your resume.
Lee Biosolutions success in the aquisition of this outstanding new facility was achieved by having a great team which included Dan Dokovic from Intelica CRE, Kelly Shamel from Greensfelder Hemker & Gale, P.C, Jack Mannebach and Stephen Kuhn of Heartland Bank, Steve Grelle from the St. Louis Economic Development Partnership and The City Of Maryland Heights.
Lee Biosolutions is a key manufacturer of high purity enzymes and related proteins that include tumor markers, cardiac markers, specialty diagnostic proteins for immunological diseases and biomarkers. The company is known internationally for developing some of the most successful formulations for research, diagnostic and therapeutic markets.